For people with atrial fibrillation (Afib), investigational abelacimab proved to be a potent dual factor XI/XIa inhibitor with much lower safety risks compared with a direct oral anticoagulant (DOAC), ...

Background Atrial fibrillation (AF) and acute myocardial infarction (AMI) share risk factors and are bidirectionally associated. Several studies found higher risks of outcomes in individuals with both ...

CALQUENCE® (acalabrutinib) plus chemoimmunotherapy approved in the US for patients with previously untreated mantle cell lymphoma ...

In an interview, the CEO discussed trying to gain support from investors hyper-focused on M&A, and competing with Pfizer and ...

The NHS Health Check is a free service for anyone between 40 and 75 in the UK and it's been found to catch heart disease and ...

Atrial Fibrillation (AF) is a common heart condition where the heart beats irregularly and often too quickly. It affects many ...

Surgery is the gold standard, GLP-1s are all the rage—whether a head-to-head study is needed depends on who you ask.

The commercialisation of junk food, increase in inactive lifestyles with prolonged sitting, and high stress environments, ...

Nutritious foods aren’t always harmless. Grapefruit juice, greens, and other staples can disrupt medications. Discover five ...

Here we take a look back at some of our research breakthroughs of 2024. January: Diet in childhood linked to blood vessel damage in teenage years We kicked off 2024 with research highlighting the ...

Researchers evaluated a drug that represents a new class of anticoagulants known as Factor XI inhibitors for treating patients with atrial fibrillation as part of the AZALEA-TIMI 71 Study. The trial ...

Patients with atrial fibrillation are typically prescribed an anticoagulant, or blood thinner, to reduce the risk of stroke, but many may discontinue them or never receive a prescription due to ...